Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,233.66
-13.2700-1.06%
Post-market: 1,232.00-1.6600-0.13%19:59 EDT
Volume:2.14M
Turnover:2.66B
Market Cap:1.17T
PE:41.41
High:1,264.73
Open:1,249.00
Low:1,229.79
Close:1,246.93
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.77
T/O Rate:0.23%
Dividend:6.69
Dividend Rate:0.54%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:34.42
PE(LYR):53.75

Loading ...

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 19

Eli Lilly EVP, International President Patrik Jonsson Disposes of 6,500 Shares Worth $7.64 Million

Reuters
·
Aug 19

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

TradingKey
·
Aug 19

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Movement Alert|Eli Lilly Rises 3.1% in Regular Trading, GLP-1 Sector Rallies as Multiple Pipeline Collaborations Provide Catalyst

Market Focus
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

OmniAb Enters $370‑Million Drug‑Development Deal With Eli Lilly

Reuters
·
Aug 17